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ABSTRACT 
Stetco , Eliana  , Gambusia affinis as a model for the investigation of inflammatory bowel 
disease, inflammation, and antibiotic usage: An exploratory study . Master of Arts 
(Biology ), December, 2019, Sam Houston State University, Huntsville, Texas. 
 
A complex relationship exists between gastrointestinal commensal microorganisms and 
their hosts. While it is not entirely understood how commensal microbiota influence the 
host immune system, it is evident that the two are largely dependent on one another. 
Disharmony of the healthy GI tract can result in chronic inflammatory bowel diseases, 
such as Crohn’s disease (CD) or ulcerative colitis (UC). In the healthy GI tract, the lower 
intestine is largely hypoxic, thus it is expected to be largely dominated by anaerobes. 
However, inflammation in the large bowel results in dysbiosis of the microflora such that 
obligate anaerobes decrease in number while the presence of facultative anaerobes 
increases. As previous literature demonstrates, this could be due to the fact that 
inflammation in the host generates reactive nitrogen and reactive oxygen species, 
molecules that facultative anaerobes can use as final electron acceptors in anaerobic 
respiration. Further, use of antibiotics could result in persistent alterations in the gut 
microbiome composition that mimic the alterations seen in the inflamed gut, as antibiotic 
use in humans sometimes improves irritable bowel conditions and sometimes worsens 
them. Fish were exposed to dextran sodium sulfate (DSS) orally, with gut inflammation 
monitored using the MPO assay, gut nitrate levels determined, and gut microbiome 
community analyzed using 16S sequencing. In conclusion, inflammation levels were 
inconsistent, possibly because these invasive fish are so resilient and DSS levels were 
insufficient, or the presence of parasites as a confounding factor. Gut community changes 
were observed but statistical significance not established. These fish are not a good model 
v 
for mammalian gut research, as they are normally dominated by facultative anaerobes, 
while mammalian by obligate anaerobes.In conclusion, it is possible that the amount  of 
DSS used in this explorative study simply is not enough to induce colitis in Gambusia 
affinis, which are known for being rather resilient fish. Furthermore, it is possible that 
wild caught Gambusia have too many inherent confounding factors to be used reliably in 
gut microbiome research and thus further work is necessary.   
 
KEY WORDS: Inflammation, Gut microbiome, Dextran sodium sulfate, Antibiotics, 
Fish, Animal model  
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The complex relationship between the host gut microbiome and the host has been 
well documented. With approximately 1014 microbial cells, which equates to more than 
ten times the number of human cells (Bull and Plummer, 2014), it is unsurprising that gut 
bacteria play critical roles in the overall well-being of the host. These microbes supply 
essential nutrients, synthesize vitamins like vitamin K, metabolize undigested food 
remnants and are implicated in mood disorders, obesity, allergies, inflammatory diseases, 
and even cancer (Mohajeri et al., 2018). It is suspected that one of the main factors in the 
increasing cases of such ailments as inflammatory bowel diseases is the disruption of the 
gut microbiome.  
The Human Gut Microbiome  
The healthy human intestinal tract, namely the large intestine where the majority of the 
gut microbiome resides, is dominated by four major groups: Firmicutes and 
Bacteriodetes and, to a much lesser degree, Proteobacteria and Actinobacteria (Morgan 
et al., 2012). Firmicutes are mostly rod-shaped, all Gram-positive, and divided into two 
classes, Clostridia and Mollicutes. Clostridia are anaerobes and divided into “clusters.” 
Of note are clostridial clusters IV and XIVa which comprise a substantial amount of the 
total gut microflora and are made up of different species of bacteria belonging to varying 
genera (Lopetuso et al., 2013). An example is Faecalibacterium prausnitzii, a strict 
anaerobe whose role is largely functional-to produce butyrate, a short-chain fatty acid 
produced by anaerobic fermentation of undigested carbohydrates. Butyric acid plays a 
role in protecting and maintaining the integrity of the intestinal barrier through the 
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production of mucins. It also has anti-inflammatory functions (Galecka et al., 2013). It 
has been observed that F. prausnitzii are significantly reduced in patients with Crohn’s 
disease and ulcerative colitis as compared to their healthy counterparts (Hippe et al., 
2011). . Bacteriodetes are Gram-negative, anaerobic, rod-shaped bacteria that, like 
Firmicutes, comprise a significant portion of the mammalian gut. Proteobacteria are 
facultative or obligate anaerobes that comprise a much smaller portion of the gut 
microbiome. In fact, Na-Ri Shin et al. describe Proteobacteria as a potential marker for 
gut dysbiosis and suggest that an increased prevalence of this phylum could be used as a 
diagnostic “signature” of risk for disease (2015). In support of this, the American Gut 
Project has found that the abundance of Proteobacteria in fecal samples can double in the 
month following antibiotic usage. However, as with other groups, the abundance of 
Proteobacteria in normal healthy donors varies, making conclusions only from 
abundance data weak. Finally, Actinobacteria include the genus Bifidobacterium, an 
anaerobic bacterium that has been well-documented and is sold as a supplement probiotic 
due to its myriad of benefits including indirect production of butyrate (via lactate), barrier 
effects, and enhancement of the immune response as is seen in IgA anti-rotavirus 
antibody activity (Piard et al., 2015). 
Host Intestinal Environment and Dysbiosis|  
It should be noted that Firmicutes and Bacteriodetes are obligate anaerobes that 
rely on fermentation of polysaccharides for growth. In the healthy GI tract, the lower 
intestine is largely hypoxic, thus it is logical that bacteria belonging to the 
aforementioned phyla thrive in this environment. In fact, it has been shown that the large 
intestine is colonized by obligate anaerobes that these microorganisms outnumber their 
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facultative counterparts (Eckburg et al., 2005; Maier et al., 2015).  However, as Winter et 
al. demonstrate, inflammation in the large bowel results in dysbiosis of the microflora 
such that obligate anaerobes decrease in number while the presence of facultative 
anaerobes increases. This, they believe, is due to the fact that inflammation in the host 
generates reactive nitrogen and reactive oxygen species, molecules that facultative 
anaerobes can use as final electron acceptors in anaerobic respiration. Thus, they 
hypothesize that these oxidized by-products, which are a natural component of host 
inflammation, are utilized by facultative anaerobes in a way that allows them to 
ultimately overcome fermenting microbes in the gut lumen (2013). Similarly, Rigottier-
Gois hypothesizes that the decrease in anaerobes with the subsequent increase in 
facultative anaerobes or even unusual aerobes may be due to the presence of oxygen in 
intestinal dysbiosis. He states that in the colonization of infants, there is first the 
appearance of facultative anaerobes like Echerichia coli and Enterococcus (2013). Based 
on supportive evidence from Grutte et al., he believes this is due to the fact that the redox 
potential immediately after birth is high (or electropositive) and that within a period of a 
few days, the facultatively anaerobic bacteria consume the available oxygen thus creating 
an electronegative environment that is hospitable to obligate anaerobes (2013). He thus 
predicts that dysbiosis in the otherwise healthy intestinal tract leads to a decrease in 
diversity and a decrease in dominant obligate anaerobes with an increase in facultative or 
even aerobic bacteria is the result of an increase in oxygen in the gut. This increase in 
oxygen is selectively advantageous for the facultative anaerobes and the aerobes that then 
outcompete their oxygen intolerant counterparts. The presence of oxygen in otherwise 
hypoxic environment, Rigottier-Gois suggests, may be the result of blood entering the 
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gastrointestinal tract during chronic inflammation and releasing hemoglobin carrying 
oxygen into the mucosa and lumen where the bacteria reside. Alternatively, the host 
inflammation itself could lead to both dysbiosis of the microbiota and an influx of 
reactive oxygen species by neutrophils.  
Inflammatory Bowel Disease  
Inflammatory bowel disease (IBD) is characterized by chronic intestinal 
inflammation and is mainly diagnosed as either ulcerative colitis (UC) or Crohn’s disease 
(CD) (Frank et al., 2007). Ulcerative colitis, as the name implies, affects the colon while 
Crohn’s disease is marked by inflammation throughout the intestinal tract. While it is not 
clear what specifically triggers these conditions, a number of susceptibility genes have 
been identified. However, with the growing incidence of IBD, genetic factors alone 
cannot explain the increase. For this reason, it is predicted that environmental factors also 
play a role.  
The involvement of the gut microbiota in the pathology of IBD has been 
highlighted. For example, evidence suggests that a deregulated immune response against 
commensal bacteria is involved in the pathophysiology of IBD (Becker et al., 2015). For 
example, it has been shown that end-products produced by commensal microbiota 
regulate the activation of immune cells and their respective cytokines which protect 
against pathogenic bacteria and that this regulation is disrupted in patients with IBD . In a 
study by Kim et al., germ-free IL-10-deficient mice, used because of their lack of both 
bacterial colonization and the anti-inflammatory cytokine, interleukin-10, were 
inoculated with E. coli, Enterococcus faecalis, and Pseudomonas fluorescens. E. coli 
induced cecal inflammation, Enterococcus faecalis induced distal colitis, and 
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Pseudomonas fluorescens did not cause cecal inflammation. In this way, the commensal 
bacteria were able to induce distinct types of colitis in IL-10-deficient mice. This study 
suggests that even in hosts with the same genetic background, distinct intestinal immune 
responses can be elicited (2017).  
Additionally, patterns in both the emergence and the suppression of certain 
bacterial families in association with IBD patients versus their healthy counterparts have 
been documented extensively in the literature. As noted by Hansen and Sartor, in a large 
study of 447 newly diagnosed pediatric CD patients and 221 non-IBD controls, an 
increase in Enterobacteriaceae, Pasteurellaceae, Veillonellaceae, Neisseriaceae, and 
Fusobacteriaceae in ileal and rectal biopsies from CD patients vs. controls was observed. 
Conversely, a decrease in members from Bifidobacteriaceae, Erysipelotrichales, 
Bacteroidales, and Clostridiales was also observed. It should also be noted that the 
authors of this study also discovered a marked difference between fecal samples and 
mucosal samples. In fecal samples there was little bacterial compositional change while 
significant changes occurred in the tissue biopsies. These findings suggest that perhaps 
fecal bacterial communities are different from mucosal and play a less critical role in the 
pathogenesis of CD (2015).  
Metagenomic studies have also tracked genes linked to IBD. For example, genes 
responsible for carbohydrate and amino acid metabolism have been noted to decrease in 
those with IBD while genes involved in the oxidative stress pathway are increased. This 
raises the possibility that changes within the gut microbiome that result in certain 
epigenetic changes could be the cause of intestinal inflammation in IBD patients 
(Matsuoka et al., 2014).  
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Use of Antibiotic Therapy  
There are a myriad of factors that play into host inflammation: diet, for example, 
as well as lifestyle, age, and genetics. All of these factors can result in a microbial 
imbalance that negatively affect the host, causing acute inflammation that, over time, can 
become chronic. Another potential factor is the use, or overuse, of antibiotic therapies. 
For example, through the analysis of 8748 patients diagnosed with IBD, Sebastian Sheer 
et al demonstrate that the use of antibiotics early in life can potentially contribute to 
inflammatory diseases later in life (2016) while Woldarska et al, using a murine model, 
show that antibiotics weaken the colonic mucosal layer, thereby predisposing the host to 
Citrobacter rodentium-induced colitis (2009). A study by J. Carlson et al., which utilizes 
a Gambusia affinis model, demonstrates that fish treated with rifampicin experience 
persistent alterations in their gut microbiome composition. This alteration increases their 
susceptibility to pathogens and osmotic stress, but not to general high bacterial numbers 
in the environment or nitrate toxicity (2017). Furthermore, little is known about the ways 
in which antibiotic use affects the gut microbiome over an extended period of time. 
Studies have shown, however, that use of antibiotics can result in permanent changes. In 
a study by Dethlefsen et al., three healthy humans who had not taken antibiotics for at 
least a year prior to the study underwent treatment with ciprofloxacin (Cp), an antibiotic 
which is deemed to be relatively benign for the gut microbiota. Using pyrosequencing, 
the participants had stool samples sequenced before, during, and after treatment. The 
researchers found that, while the communities among participants remained relatively 
stable, when comparisons were made across the individuals the relative abundance levels 
of approximately 30% of the taxa in the gut were affected by Cp treatment. Additionally, 
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some taxa within a single individual were found to respond to Cp. Of note, while gut 
function within the communities remained normal, implying functional redundancy 
among bacteria, the more specialized functions (such as immune regulation) cannot 
necessarily be implied (2008). 
The authors continued this study and published data a few years later. Here, the 
researchers observed a dramatic shift in community composition 3-4 days post Cp 
treatment. Upon discontinuation of Cp treatment, the community returned to a state that 
more closely resembled the pre-treatment state. Surprisingly, this return occurred despite 
the fact that dominant taxa constituting 25-50% of the community was demolished after 
exposure to Cp. By the end of the study, community composition differed from what it 
had been before the first course of antibiotic treatment, but each new state was stable over 
the final 2 months of the study. Moreover, the communities appeared to display 
functional redundancy which is perhaps the reason for an absence of negative symptoms 
experienced by the participants. It should be noted that while this data illuminates 
potential features of the gut microbiome (such as resilience and functional redundancy) 
and highlights the intricacies and intravariation between individuals, understanding of 
this complex ecosystem is limited. In this way, while one individual may not be affected 
by a particular antibiotic, another may experience community shifts that impact 
susceptibility to certain pathogens or that result in the expression of genes involved in the 
oxidative pathway and thus increase the likelihood of inflammatory conditions (2010). .  
Current Models of IBD  
The most well-established model of IBD is the murine model, primarily the 
mouse model. Mice have been used to investigate the intricate relationship between the 
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gut microbiome, immune system, and genetic susceptibility. The type of mouse used 
depends largely on the investigative question. For example, when investigating the causes 
of inflammation and their respective pathways, SCID or RAG1-/- may be used due to their 
immune deficiency. Alternatively, when investigating the role of specific cytokines, 
interleukin deficient mice will be used, such as IL18-/- or IL10 -/- (Keisler et al., 2015).  
In this way, the role of immune pathways and the ways in which particular immune cells 
function can be studied. Due to the similarity of their bacterial composition to humans 
and their ability to be genetically manipulated, the use of such mice has provided 
investigators with a robust amount of data and has illuminated aspects of IBD 
pathogenesis, such as the role of resident microbiota in driving intestinal inflammation, 
and has led to the discovery of such susceptibility genes as NOD2 in Crohn’s disease 
(Knights et al., 2013).  
The use of these models, while extensive, are not exhaustive and factors such as 
high cost, imaging limitations, and longer lifespan have led researchers to turn to other 
models such as fish models. Common fish models include the rainbow trout, common 
carp, zebrafish, and poecilia. The GI tracts of these models are predominantly comprised 
of Proteobacteria, Bacteroidetes, Actinobacteria, Firmicutes and Fusobacterium phyla. 
However, diet and environment play highly influential roles in the composition of the 
microbiota in fish species. For example, marine fish are dominated by facultative 
anaerobes including Vibrio, Pseudomonas, Acinetobacter, Corynbacterium, Alteromonas, 
Flavobacterium, and Micrococcus while freshwater fish are dominated by Aeromonas, 
Pseudomonas, and Bacteroides (Egerton et al., 2018). 
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In fish, bacterial colonization during the larval stage is significantly impacted by 
the microbiota of the eggs, water, and feed and a stable indigenous microbiota is 
established by the post-larval stage. The temperature and salinity of water are two main 
factors impacting the intestinal microbiota of fish as these two factors affect the relative 
abundance and type of bacteria present in the water. Additionally, and similarly to 
humans and mice, diet and the feeding habits also impact the gut microbiota of fish. For 
example, whether fish feed is plant or fish oil based impacts the dominant phyla 
present19. Moreover, whether fish are omnivores, carnivores, or herbivores also affects 
the microbiota present, a trend that has been observed in humans( Egerton et al., 2018)..  
While many fish models are currently being utilized for antibiotic investigation on the gut 
microbiome, the research is often directed toward fish farming and practices. The use of 
zebrafish, on the other hand, is showing promise in the realm of IBD research. This is 
perhaps because zebrafish are easy to cultivate, have a generation time of about 3-4 
months, have a gastrointestinal tract that is markedly similar to those of humans, and 
show orthologs for over 70% of human genes (Hanyang et al., 2017). . 
Zebrafish models of IBD include three types: wild type, mutant, and transgenic. In this 
way, zebrafish can be manipulated in a similar way to murine models. Moreover, 
zebrafish larvae have been used for imaging purposes due to their transparency. For 
example, in a study by Renshaw, transgenic zebrafish larvae that expressed GFP under 
the neutrophil-specific myeloperoxidase promoter was used to visualize and analyze the 
inflammatory response after tissue injury (2006). In this way, observations were made 
without the need to kill the fish, which is often necessary with murine models as 
pathological changes cannot be determined by observation  
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Currently, Gambusia affinis has not been established as a definitive model for 
investigating IBD. We propose that Gambusia affinis, because it has the necessary 
components of a vertebrate immune system, may be a viable model for the investigation 
of gut microbial composition as it relates to inflammation and the use of antibiotics. 
Additionally, Poecilia fish (the family to which Gambusia affinis belong) are an 
interesting model for microbiome studies as they are highly adaptable, capable of living 
on a wide range of diets and under a wide range of environmental conditions, including 
that of the laboratory environment (Schmidt et al., 2017).  
 In order to study inflammation in this model, dextran sulfate sodium (DSS) will 
be used to induce clinical-grade colitis in the animals.  A theory by which DSS induces 
inflammation is that damage to the colonic epithelium results in the invasion of luminal 
bacteria and their respective antigens into the mucosa which result in proinflammatory 
responses (Eichele et al., 2017).  More specifically, it has been observed that dextran 
sodium sulfate molecules link with medium-chain-length fatty acids (MCFAs) that are 
present in the colonic lumen and that these complexes in particular are what activate 
intestinal inflammatory signaling pathways (Laroui et al., 2012). DSS has been used in 
numerous studies as an effective way to research inflammatory bowel diseases in animal 
models, including mice, rats, and zebrafish.  Thus, we predict that inflammation induced 
by DSS will affect the gut microbiome of the Gambusia affinis similarly to treatment 
with rifampicin, a broad spectrum antibiotic, in terms of shifts within bacterial 
communities and types of bacterial communities present. In this way, we hope to 
demonstrate that use of antibiotics disrupts the host gut microbiome in a way that can 
ultimately induce acute inflammation.  
11 
 
Inflammation itself will be gauged using a well-established myeloperoxidase 
assay. Myeloperoxidase (MPO) is a heme-containing peroxidase expressed mainly in 
neutrophils in response to tissue damage and microbial invasion. In animal and human 
studies, MPO is used as a biomarker to measure the amount of inflammation present in 
tissue as MPO levels often correlate with the number of neutrophils present (Bradley et 
al., 1982). . For example, Kim et al describe treating a murine model with DSS and 
measuring the severity of the induced acute colitis using an MPO assay, as an increase in 
MPO is often correlated with the extent of tissue damage (Kim et al., 2012).  
Additionally, zebrafish have gained popularity as a reliable model in which to study 
inflammation.  For example, Pase L et al describe a mechanism of healing following 
tissue injury that involves the downregulation of hydrogen peroxide by myeloperoxidase 
using wild type, leukocyte-depleted, and myeloperoxidase-deficient zebrafish models 
(2018).  Thus, DSS and the MPO assay are often used as inexpensive and reliable 
methods to induce and quantify inflammation and investigate such aspects of 
inflammatory bowel disease as disease progression, relationship to genetic factors, and 
impact on the gut microbiome. It should be noted, however, that DSS has only been used 
in zebrafish larvae in order to study mucus production (Fenero et al, 2016). To date, no 
study has used a DSS fish model to study changes in the gut microbiome.  
Hypotheses 




1) Inducing inflammation via DSS in the gut of the Gambusia affinis will result in 
changes in the community composition of the microbiome and specifically raise the 
abundance of facultative anaerobes, presumably due to the presence of nitrate.  
2) Treating Gambusia affinis with rifampicin will result in measurable 








MATERIALS & METHODS 
Part 1. Materials, Equipment, & Techniques  
Chemicals 
 Solutions were prepared in the lab and autoclaved using standard procedures 
when necessary. Suspensions of antibiotic or biocide compounds were not sterilized 
when in pure DMSO (dimethyl sulfoxide).  
Media 
All media for plating were prepared in the lab and autoclaved using standard 
procedures. Media containing heat-sensitive components, such as dextran sodium sulfate, 
were heated first and then had the substance added after a brief cooling period of 2-5 
minutes for 1.5 mL of solution. All empty petri dishes used were purchased from VWR, 
sterilized upon purchase, and remained sealed until use.  
Equipment, Miscellaneous Items 
All equipment was sterilized as necessary using a glassware oven (90°C for >2 
days), and items such as alcohol wipes remained sealed until time of use where they were 
only opened in the BioSafety Cabinet (BSC). All results requiring opening of plates were 




Part 2. Media & Solutions.  
 Artificial Pond Water (APW) 
APW was made using 3 L of sterile MilliQ water, 0.333 g calcium chloride, 0.333 
g magnesium sulfate, and 0.119 g sodium acetate. Ingredients were placed into a large 
glass jar and autoclaved with a 30-minute sterilization time. APW was used as sterile 
water in the experiment outlined below and is designed to mimic salt content in natural 
systems.  
 Preparation of Phosphate-Buffered Saline with Tween 80% (PBST) 
PBST was prepared by adding fibe PBS (phosphate-buffered saline) tablets (Item 
# E404-100TABS, Amresco©) and 250 µL Tween 80 to 500 mL of MilliQ water. Final 
concentrations of solutes in PBST solution were 2 mM NaCl, 10 mM KCl, and 137 mM 
PO43- resulting in pH 7.4. The solution was autoclaved at 121°C under pressure with a 
sterilization time of 15 minutes.  
 Preparation of Sterile MilliQ Water 
Water filtered through a MilliPore system (look up manufacturer) was collected 
and autoclaved 0.5 L at a time with 15-minute sterilization time, using standard 
procedures. 
 Nutrient Agar (NA) Plates 
 NA was prepared by adding 2.5 g peptone, 1.5 g beef extract, and 7.5 g of agar to 
500 mL MilliQ water. Once combined, the solution was placed on a stir plate to ensure 
mixing and then autoclaved at 121°C for 15 minutes. The solution was removed from the 
autoclave and allowed to cool on a stir plate for a minimum of 10 minutes before pouring 
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into sterile petri dishes. Once poured, NA plates were allowed to cool and harden before 
being sealed and stored at 4°C until use.  
 Nitrate Agar Plates 
Nitrate agar was prepared by adding 9 g of pre-prepared nitrate broth powder and 
12 g of agar to 1000 mL of distilled water. Once combined, the solution was placed on a 
stir plate to ensure mixing and then autoclaved at 121°C for 15 minutes. The solution was 
removed from the autoclave and allowed to cool on a stir plate for a minimum of 10 
minutes before pouring into sterile petri dishes. Once poured, nitrate agar plates were 
allowed to cool and harden before inoculation conducted in the BioSafety Cabinet (BSC).  
Part 3. Sampling & Analysis. 
 Section 1. Specimen Collection & Maintenance.  
 Specimen Collection. The fish used in this study, Gambusia affinis (G. affinis), 
were collected from the Woodland Hills Lake throughout the length of this study using 
dip nets. Woodland Hills Lake was chosen due to previous studies also using fish from 
this location. The lake is pristine and in a neighborhood located in Walker County outside 
the Huntsville city limits at 30 degrees 49 minutes 23 seconds North by 95 degrees 32 
minutes 34 seconds West (derived from Google Maps on 2/10/2019). All fish collected 
were brought back to the lab in the Lee Drain Building (LDB) room 125A (2017-2018) 
and the Life Sciences Building (LSB) room 370 (2018-2019) at Sam Houston State 
University (SHSU), acclimated in the buckets in which they were collected for 3 days, 
and then placed in aquariums and given a minimum of one week for their microbial flora 
to homogenize and stabilize. Fish were fed store-purchased fish flakes on an average of 
4-5 times per week. All experiments were carried out after the minimum homogenization 
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time period passed. Aquaria were initially filled with 50% lake water and 50% tap water 
and kept on a 12-hour light/12-hour dark cycle. The room temperature varied from 21-
23°C.  
 Location. All experiments were performed at SHSU in either LDB 125A or LSB 
370 with IACUC approval (ID# 18-10-16-1018-3-01). 16S DNA profiling sequencing 
was performed by MR DNA in Shallowater, Texas. Data analysis occurred at SHSU.  
 Fish Handling. Fish were removed from aquaria, buckets, containers, etc. using 
small fish nets. When handled, fish were grabbed gently but firmly by the tail through the 
net with gloved fingers for direct removal from the net. All efforts were made to reduce 
the amount of stress experienced by the fish by handling the fish quickly and efficiently.  
 Section 2. Acquiring Microbiome Samples.  
 Gut Microbiome Sampling. To sample the gut microflora of G. affinis, fish were 
individually removed from the aquarium or experiment container using a small net and 
carefully placed into a sterile petri dish to be weighed. Once weighed, fish were removed 
from the petri dish, held between the thumb and forefinger of one hand and gently 
cleaned with an alcohol wipe using the other hand. Once wiped, fish were placed into a 
new, sterile petri dish. All tools were cleaned with alcohol wipes. Using small forceps 
and dissecting scissors, the spinal cord was severed between the forward fins and the 
eyes. Once the spinal cord was severed in this manner, the tools were once again cleaned 
with alcohol wipes. Once cleaned, the gut was located and removed by cutting the 
intestines at the esophagus and anus. The gut was then cut into small pieces and placed 
into either a 1.5 mL centrifuge tube containing HTAB or PBST, depending on the 
experiment to be carried out.  
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*Each sample equals one fish. Once a fish was sampled, it was removed from the 
associated experiment completely. In this way, each fish was only sampled once. 
 Section 3. Quantitation of Microflora.  
Colony Forming Units (CFU) – Plating. Fish intestines were excised, cut into 
pieces, and placed into a 1.5 mL centrifuge tube containing 1000 µL PBST. The tube was 
then vortexed for 2 minutes after which a 100 µL aliquot was plated onto nitrate and 
nutrient agars. Once completed, 100 µL was removed again and placed into a 1.5 mL 
centrifuge tube containing 900 µL of PBST. In this way, 1:10 serial dilutions were 
performed with the highest dilution plated being 10 – 3. The suspensions plated were 
spread with sterile spreaders, beginning with the most dilute sample to the 1X sample. 
Plates were then incubated in either aerobic or anaerobic conditions (designation was 
carefully labeled prior to plating) at room temperature (25°C) for a minimum of 48 hours. 
After a minimum of 48 hours, all plates were observed for colony counts.  
*Because the samples plated were whole-community samples, pure colony counts 
were not possible; various morphologies were considered to be a single colony.  
Section 4. 16S rRNA Sequencing.  
Samples for 16S DNA Extraction using MoBio PowerSoil DNA Isolation Kit. 
Samples for DNA extraction were removed from freezer and thawed on ice. After 
thawing, 0.010 g – 0.020 g of the sample was added to a MoBio PowerBead tube and 
vortexed approximately 5 – 15 minutes until the sample was homogenized. Samples were 
then incubated for 10 minutes at 65°C and then 10 minutes at 95°C in a heat block. Next, 
tubes were incubated at -80°C overnight. The sample tube was removed from the -80°C 
freezer and thawed at room temperature for 30 – 60 minutes. After thawing, 60 µL of 
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solution C1 was added and the tube was vortexed for five seconds. The tube was then 
vortexed at maximum speed for 10 minutes, and 250 µL of solution C2 was added to a 
clean Collection Tube. The PowerBead tubes were removed from the vortexer and 
centrifuged at 10,000 x g for 30 seconds at room temperature. The PowerBead tubes were 
removed from the centrifuge and the supernatant was transferred to the Collection Tube 
containing solution C2. The Collection Tube was vortexed for five seconds and incubated 
at 4°C for five minutes. Next, 200 µL of solution C3 was added to a clean 2 mL 
Collection Tube. The incubated Collection tubes were removed from the refrigerator and 
centrifuged for one minute at 10,000 x g. From the centrifuged sample in the first 
collection tube, 600-650 µL was transferred to the second Collection Tube containing 
solution C3; the tube was vortexed for five seconds and then incubated at 4°C for five 
minutes. After incubation, samples were removed from the refrigerator and centrifuged at 
10,000 x g for two minutes at room temperature. From the centrifuged sample, a 
maximum of 750 µL was transferred to a third clean Collection Tube already containing 
1 mL of solution C4 and vortexed. Next, 600 – 630 µL of vortexed sample was loaded 
onto a Spin Filter and centrifuged at 10,000 x g for one minute at room temperature; flow 
through was discarded and this process was repeated for a total of three times to process 
the entire sample. Then, 500 µL of solution C5 was added to the Spin Filter and 
centrifuged at 10,000 x g for 30 seconds at room temperature; flow through was 
discarded. The Spin Filter was centrifuged again at 10,000 x g for one minute at room 
temperature. The Spin Filter was then placed into a clean Collection Tube and 55 µL of 
sterile DNA-Free Molecular Biology Grade water added to the center of the white filter 
membrane. The tube was centrifuged at 10,000 x g for 30 seconds, the filter was 
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discarded, and the supernatant was transferred to the Stock-DNA tube. Extraction DNA 
concentrations were measured and stored at -80°C.  
Samples were then mailed to MR DNA in Stillwater Texas.  
PCR Amplification and Processing. The primers 515 and 806 were used to amplify the 
V4 variable region of the 16S rRNA gene in a single-step 30 cycle PCR using the 
HotStarTaq Plus Master Mix Kit (Qiagen, USA) under the following conditions: 94°C for 
3 minutes, followed by 30 cycles (5 cycle used on PCR products) of 94°C for 30 seconds, 
53°C for 40 seconds and 72°C for 1 minute, after which a final elongation step at 72°C 
for 5 minutes was performed. Sequencing was performed at MR DNA 
(www.mrdnalab.com, Shallowater, TX, USA) on an Ion Torrent PGM following the 
manufacturer’s guidelines. Sequence data were processed using a proprietary analysis 
pipeline (MR DNA, Shallowater, TX, USA). In summary, sequences were depleted of 
barcodes 
and primers, then sequences <150bp removed, sequences with ambiguous base calls and 
with homopolymer runs exceeding 6bp were also removed. Operational taxonomic units 
(OTUs) were generated and chimeras removed. Operational taxonomic units were 
defined by clustering at 3% divergence (97% similarity). Final OTUs were taxonomically 
classified using BLASTn against a database derived from RDPII 
(http://rdp.cme.msu.edu) and NCBI (www.ncbi.nlm.nih.gov).  
Part 4. Protocol Development 
The experiments listed here are those that were performed to determine the best 
variables for experimental success such as toxicity levels of chemicals and appropriate 
treatment conditions.  
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Section 1. Inflammation.  
Preparation of Dextran Sulfate Sodium (DSS) Food Mixture.  
To make the modified gelatin feed, fish flakes were crushed into fine power (must be fine 
so as to avoid clogging the pipette tips) and kept in a sealed container under dry room 
temperature conditions. Next, 52 mg of gelatin was added to 360 µL of MilliQ water in a 
2 mL microcentrifuge tube and placed on a heat block at a temperature range of 60°C – 
80°C to fully dissolve. Once the gelatin was dissolved, the mixture was vortexed for 
approximately 10 seconds. Following thorough mixing, 40 mg of crushed fish food was 
added along with 20 µL fish oil and vortexed for another 10 seconds to ensure equal 
distribution. This mixture constitutes the gelatin feed for the control fish. For the 
experimental fish, the addition of 20 mg dextran sulfate sodium (DSS) was added and 
mixed well. A P200 pipette was used to make 20ul aliquots of this mixture pipetted onto 
Parafilm for easy handling. The gelatin feed was then allowed to solidify and served in 
quarters by cutting with a razor blade (1 serving=4 pieces).  
Dextran Sulfate Sodium (DSS) Experimental Group. (#1) For the first pre-
trial, 3 control fish and 6 experimental fish were used. Fish were individually removed 
from the aquarium, weighed, and placed into Styrofoam cups filled with 10 mL artificial 
pond water (APW). Once placed into their individual cups, fish were fed food combined 
with gelatin for both easy administration and so that the amount eaten by each fish could 
be tracked: control fish received food containing only fish flakes and fish oil while 
experimental fish received fish flakes, fish oil, and 2 mg dextran sulfate sodium (DSS). 
The amount eaten was then recorded every hour for a minimum of 5 hours. 12 hours 
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post-ingestion, all of the fish were sacrificed in order to obtain myeloperoxidase (MPO) 
readings and assess level of success at inducing inflammation.  
(#2) For the second pre-trial, the experiment was carried out exactly as described 
in the first pre-trial, however, this time the fish were starved for 3 days to ensure hunger. 
Additionally, the amount of dextran sulfate sodium was increased to 6 mg. The decision 
to increase the amount of dextran was made due to the apparent success at inducing 
inflammation in the experimental fish in the first pre-trial. It was also important to test 
toxicity levels. Again, MPO measurements were recorded.  
(#3) For the third pre-trial, the experiment was carried out exactly as the first and 
second, only this time 4 control and 4 experimental fish were used. Additionally, the 
amount of dextran added to the fish food was increased to 20 mg. The decision to 
increase the level of dextran to more than three times the amount in the second pre-trial 
was to, once again, ascertain toxicity levels. As dextran has not yet been studied in 
Gambusia affinis, it was necessary to gauge the amount that the fish could safely ingest. 
MPO readings were recorded.  
Myeloperoxidase (MPO) Assay. The Myeloperoxidase assay is a marker for 
neutrophils. The MPO is present in neutrophils as they carry out antimicrobial functions. 
A widely recognized marker of inflammation in a tissue is infiltration by neutrophils. 
Thus, measuring MPO activity in the gut is a reliable quantitative measure for 
inflammation. The myeloperoxidase assay functions by the presence of MPO which 
catalyzes the oxidation of o-dianisidine, a commonly used peroxidase substrate, to 
generate an orange product which is measured by an increase in absorbance at 450 nm. 
The colonic pieces were weighed then homogenized in 
22 
 
0.5%hexadecyltrimethylammonium bromide in 50 mM PBS. Samples were placed in an 
ice bath and bead beaten at maximum capacity for 2 minutes after which they were 
placed back in the ice bath for 5 minutes. This was repeated 3-5 times until tissue 
samples were thoroughly homogenized. Following the last beating, samples were 
centrifuged at 1400 for 3 minutes.  MPO activity was measured by adding 10 µL 
supernatant to a cuvette containing 326 µL phosphate buffered saline (PBS), 67 µL o-
dianisidine dihydrochloride (o-danisidine), and 6.7 hydrogen peroxide (H2O2). The 
optical density was measured at 450 nm.  
The cuvette was first filled with 426 µL PBS and the spectrophotometer was calibrated. 
Next, 100 µL of PBS was removed and 67 µL of o-dan was added. A measurement was 
recorded. Next, 10 µL of lysate was added and a reading recorded. Finally, 6.7 µL of 
H2O2 was added and a reading was recorded from 0 – 120 seconds.  
MPO activity is measured in MPO U/mg tissue where one unit of MPO is defined 
as the amount needed to degrade 1 μmoL of H2O2 per minute at room temperature. 
Considering that one unit (U) of MPO= 1 μmoL of H2O2 split and that 1 μmoL of H2O2 
gives a change of absorbance of 1.13 x 10-2 nm/min, units of MPO in each sample were 
determined as the change in absorbance [ΔA(t2-t1)]/Δmin x (1.13 x 10-2). To get units per 
mg of tissue, a tissue: buffer ratio was utilized. For example, if a tissue: buffer ratio of 7 
mg/mL was used, in 10 μL of lysate, there is 0.07 mg of tissue. Therefore, to get units per 
mg tissue, divide the units of MPO by 0.07. 
Nitrate Assay. Another recognized marker of inflammation is the nitrate anion 
(NO-3). To determine proper measurements of reagents, several trials were conducted. 
First, a standard solution was made containing 6.79 mg sodium nitrate (BA code 2263) in 
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6790 µL MilliQ. Next, the reagent was made using 29.3 mg diphenylamine, 7032 µL 
sulfuric acid, and 1758 µL MilliQ. Sample 1 utilized 100 µL of the standard solution, 
followed by the addition of 450 µL reagent, 425 µL sulfuric acid, and 90 µL MilliQ. 
Readings were recorded at 597 nm and determined to be much too high (approximately 5 
abs). Sample 2 was conducted in exactly the same manner, however, only 10 µL of the 
standard were added to the mixture. In this case, absorbance was still too great at 2.7. 
Therefore, 4 tenfold dilutions were made. In this way, Sample 3 contained 100 µL of a 
10-2 dilution. Here, it was observed that lower concentrations of the standard require 
longer times to react (0.085 at 10 minutes, 0.13 at 20 minutes, 0.14 at 25 minutes). 
It was unclear how the reaction was affected by MilliQ quantities, so for samples 
4-7, varying amounts of MilliQ were used. In Sample 4, 25 µL of the standard were 
added to 450 µL of reagent, 425 µL of sulfuric acid, and 75 µL of MilliQ which resulted 
in an absorbance reading of 4.3. For Sample 5, 2.5 µL of the standard were added to the 
same quantities of reagent and sulfuric acid, however, 97.5 MilliQ was added. This 
resulted in an absorbance reading of 0.64, a reading similar to that noted in the literature.   
It was also necessary to ascertain ideal sample volumes. For samples 1-5, sample 
volumes ranged between 100 – 190 µL. For Sample 6, a sample volume of 400 µL was 
measured which resulted in an absorbance reading of 0.02. In this way, it was determined 
that the sample volume should not be changed to greater than 200 µL. As a final 
consideration, Sample 7 contained 2.5 µL of the standard, 450 µL of the reagent, 325 µL 
of sulfuric acid, and 197.5 µL of MilliQ. While this sample volume was double that of 
Sample 5, it nevertheless resulted in similar absorbance readings (0.61 at 4 minutes and 
0.71 at 5 minutes). Thus, after numerous trials, it was determined that the standard is best 
24 
 
used in smaller amounts (between 2.5-10 µL), the reaction takes time and can vary 
between samples, and sample volumes are best kept at 200 µL.  
*Upon application of this assay on samples from the experiment, it was 
determined that 10 µL of a 10-2 dilution of sample added to 450 µL reagent, 325 µL 
sulfuric acid, and 190 µL MilliQ resulted in absorbance readings that remained 
consistent across samples.  
Once absorbances for each sample were recorded, a standard curve was made and 
the stable absorbance for each was plotted against the equation obtained from the 
standard curve in order to obtain the concentration of nitrate anion. The resulting 
concentration was then divided by the weight of the fish, µg/g.  
Histological Assessment of Inflammation. Gut samples utilized for histological 
evaluation were excised from the control and treatment fish on Days 1, 3, and 7. Samples 
were spun into tight coils and placed in 2 mL microcentrifuge tubes containing 10% 
neutral buffered formalin made on 3-17-2015. The tubes were meticulously sealed with 
parafilm and placed in a small Ziplock bag that was mailed to Dr. Kendra Rumbaugh in 
the Department of Surgery at Texas Tech University Health Sciences Center.  
The slides and staining were done through an automated process in the in-house 
pathology lab at Texas Tech University Health Sciences Center. The staining followed a 
basic Haemotoxylin and Eosin (H&E) protocol. First, sections were deparaffinized and 
Haemotoxylin was added for 4 minutes and then dipped in Acetic H2O. Then samples 
were placed into H2O for 1 minute and again for 30 seconds followed by 1% ammonia 
for 3 seconds, H2O for 40 seconds, 95% ethanol for 10 seconds, and Eosin for 1 minute, 
followed by quick dehydration of slides in 95% ethanol and absolute ethanol twice for 10 
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seconds and again for 20 seconds. Lastly, the slides are cleared in several changes of 
xylene at 30 seconds. Every step is conducted at 65ºC.  
Once slides were stained, Dr. Derek Fleming, post-doctoral research associate under Dr. 
Rumbaugh at Texas Tech University Health Sciences Center, analyzed the slides with no 
prior knowledge of which samples the sections represented so that he would not run the 
risk of subconscious bias. Impressions were documented and sent to our laboratory for 
further analysis.  
Section 2. Antibiotic Treatment.  
Rifampicin Experimental Group. Based on previous studies conducted in the laboratory, 
an established protocol was used to treat fish with rifampicin. A rifampicin stock solution 
was prepared by adding powdered rifampicin to room temperature dimethyl sulfoxide 
(DMSO) and vortexed to create a 50 mg/mL stock solution. 500 µL of the stock solution 
was added per liter of APW (25 µg/mL final concentration). It was calculated that this 
amount of the antibiotic equates to approximately 25 mg/kg dose while dosages 
recommended to humans are 10 – 20 mg/kg. In this way, this is a high-dose model. 
 Fish were placed into individual Styrofoam cups filled with 100 mL of the 25 
µg/kg solution. Fish were fed the same feed as the control group and given 24 hours to 
eat. The following day, the rifampicin treated APW was discarded and replaced with 
clean APW. In this manner, rifampicin treated fish were only exposed to the antibiotic for 






Schematic of Experimental Design: 
 
 
As illustrated, fish are placed into individualized Styrofoam cups. “D” is for days, 
“C” is for control, “E” is for DSS-treated group, and “R” is for rifampicin antibiotic-
treated group. The timing of 1, 3, and 7 days after treatment was selected because 
inflammation takes some time to appear and so it is important to capture prior, during, 
and after inflammation.  
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CHAPTER III  
RESULTS  
Part 1. Protocol Development.  
DSS and MPO levels. The first dextran sulfate sodium pre-trial revealed that samples 
taken from fish treated with very low levels of DSS (2 mg) result in absorbance readings 
that are both inconsistent and too similar to samples taken from control fish (Tables 1a 
and 1b).  
Table 1 
Absorbance readings: control vs dextran sodium sulfate treated fish  
Note: Myeloperoxidase absorbance readings taken every 30 seconds from 0-120 seconds 
at 450 nm for control (non-DSS treated) fish and experimental (DSS-treated) fish. E2 not 











Control fish (MPO absorbance readings) Dextran Sulfate Sodium fish (MPO absorbance readings)
C1 C2 C3 E1 E3 E4 E5 E6
0.0933 0.0465 0.0161 0.0276 0.0202 0.0237 0.018 0.0467
0.0838 0.0444 0.0249 0.0318 0.0215 0.0251 0.0198 0.0714
0.0991 0.0486 0.0347 0.0334 0.0302 0.0290 0.0218 0.0793
0.1152 0.0544 0.0458 0.0372 0.0349 0.0339 0.0238 0.0898




Calculated MPO units and units/gram of control vs dextran sodium sulfate treated fish 
Note: Myeloperoxidase activity is measured in units (U) of MPO/g tissue. Numbers are 
then compared across samples to determine level of inflammation. A “0” indicates a lack 
of enzyme activity 
 
A second pre-trial, however, revealed that the addition of 6 mg DSS to gelatin fish food 
resulted in increased absorbance readings (and thus enzyme activity) as well as more 
consistent readings overall. Here, the control fish samples consistently showed little MPO 
enzyme activity while the DSS treated fish samples suggested MPO was increased in the 




















 Absorbance readings: control vs dextran sodium sulfate treated fish  
Note:Myeloperoxidase absorbance readings taken every 30 seconds from 0-120 seconds 
at 450 nm for control (non-DSS treated) fish and experimental (DSS-treated) fish. 
 
Table 4 
Calculated MPO units and units/gram of control vs dextran sodium sulfate treated fish 
Control(C)Fish/ 
MPO U MPO U/g 
DSS(E)Fish 
C1 0 0 
C2 -0 00 
C3 2.013 6.3 
C4 0 0 
E1 .920 1 
E2 .655 1.2 
E3 .619 .8 
E4 .402 1.2 
Note: Myeloperoxidase activity is measured in units (U) of MPO/g tissue. Numbers are 
then compared across samples to determine level of inflammation. A “0” indicates a lack 
of enzyme activity.  
 
Based on the results from the second pre-trial, DSS was increased further to 20 mg in an 
attempt to discover whether larger amounts of this colitogen would result in increased 
levels of MPO, and thus inflammatory infiltrates of neutrophils within the gut of the fish. 
It was also not known whether the addition of this amount of DSS would cause lethality 
C1 C2 C3 C4 E1 E2 E3 E4
0.1776 0.1745 0.0513 0.0344 0.0734 0.0579 0.0950 0.0444
0.1644 0.1745 0.0663 0.0384 0.0827 0.0599 0.0950 0.0467
0.1460 0.1439 0.0747 0.0328 0.0927 0.0627 0.1082 0.0461
0.1321 0.1417 0.0873 0.0322 0.0898 0.0673 0.1083 0.0499
0.1261 0.1420 0.0968 0.0287 0.0942 0.0727 0.109 0.0535
Control fish (MPO absorbance readings) 




in the fish.  
Results from the third pre-trial incorporating 20 mg DSS indicated that the fish could not 
only survive this dosage, but that in some cases it was sufficient to raise MPO levels 
slightly above those recorded at 6 mg dosage (Tables 3a and 3b).  
Table 5 
Absorbance readings: control vs dextran sodium sulfate treated fish 
 
Note: Myeloperoxidase absorbance readings taken every 30 seconds from 0-120 seconds 




Calculated MPO units and units/gram of control vs dextran sodium sulfate treated fish 
Control(C)Fish/ 
MPO U MPO U/g DSS(E)Fish 
C1 0 0 
C2 0 0 
C3 0 0 
C4 0 0 
E1 1.062 1.4 
E2 .783 1.7 
E3 .584 .8 
E4 .040 .1 
Note: Myeloperoxidase activity is measured in units (U) of MPO/g tissue. Numbers are 
then compared across samples to determine level of inflammation. A “0” indicates a lack 
of activity.  
 
C1 C2 C3 C4 E1 E2 E3 E4
0.0595 0.1423 0.1874 0.0659 0.0539 0.047 0.0396 0.0393
0.0566 0.1379 0.1726 0.0588 0.0628 0.0556 0.0485 0.0335
0.0526 0.1288 0.1797 0.0586 0.058 0.0554 0.0519 0.033
0.0538 0.117 0.186 0.0579 0.0649 0.0609 0.0531 0.0367
0.0559 0.1125 0.1789 0.0591 0.0779 0.0647 0.0528 0.0402
Control fish (MPO absorbance readings) 





Statistics for MPO pre-trial assays. Pre-trial 1 
 
Note: When comparing the means of the control versus the DSS-treated fish in the first 
pre-trial with 2 mg DSS, there is no statistical difference between the three control fish 
and the five DSS-treated fish.  
 
Table 8  
Pre-trial 2 
 
Note: When comparing the means of the control versus the DSS treated fish in the second 
pre-trial with 6 mg DSS, there is no statistical difference between the four control fish vs 





































Note: When comparing the means of the control versus the DSS treated fish in the third 
pre-trial with 20 mg DSS, there is no statistical difference the four control vs the four 
DSS treated fish.  
 
Nitrate. Based on Winters et al. hypothesis that host derived nitrate increases the growth 
of facultative anaerobes in the inflamed gut, it was necessary to test nitrate levels within 
the gut of the sample fish. However, before assessment of the experimental samples 
































Figure 1. Example of standard curve constructed for successful nitrate anion assays. 
Sample concentration as micrograms per milliliter with absorbances: 10/.13 and 25/.64. 
The line having y-axis intercept of 0.034 with r2 = 1.  
 
Part 2. Experimental Results.  
DSS and MPO levels.  MPO levels in the fish, as indicated by the MPO assay, 
were inconsistent. The Day 1 and, most notably, the Day 3 control fish revealed higher 
levels of inflammation than the DSS treated fish. While the Day 7 fish followed more 
expected patterns across samples, the MPO levels in the DSS treated fish were not 
markedly pronounced as compared to the control fish. This is suggestive of variables and 
confounding factors likely inherent in the fish that may play roles in encouraging or 
attenuating inflammation and that ultimately may interfere with consistent and 










Calculated MPO units/gram for Experimental Run Day 1 
                                                                            
        
Note: Absorbances not shown. MPO activity is measured in units/g tissue. The change in 
absorbance is divided by time and then divided  by 1.13 x 10-2 nm/min (the change of 
absorbance in 1 μmoL of H2O2) and divided by respective tissue to buffer ratio.  (based 





Calculated MPO units/gram for Experimental Run Day 2 
 




Calculated MPO units/gram for Experimental Run Day 3 
                 
 
Nitrate.  Based on absorbance values from the standards, it was determined that 10 ul of 
sample would be necessary and sufficient to run nitrate assays.  
 
















Figure 2. Absorbency versus time in day 1 control sample. Readings started after 5 
minutes of reaction time and were read at 597 nm every 1-5 minutes until stabilization  
occurred.  Stable absorbance number was 0.0728.  
 
 
Figure 3. Absorbency versus time in day 1 DSS-treated sample. Readings started after 5 
minutes of reaction time and were read at 597 nm every 1-5 minutes until stabilization 





Figure 4. Absorbency versus time of day 1 antibiotic-treated sample. Readings started 
after 5 minutes reaction time and taken every 1-5 minutes until stabilization occurred. 
Stable absorbance number was 0.0656.  
 
 
Figure 5. Absorbency versus time of day 3 control sample. Readings started after 5 
minutes reaction time and taken every 1-5 minutes until stabilization occurred.  




Figure 6. Absorbency versus time of day 3 DSS-treated sample. Readings started after 5 
minutes reaction time and taken every 1-5 minutes until stabilization occurred. Stable 
absorbance number was 0.048.  
 
 
Figure 7. Absorbency versus time of day 3 antibiotic-treated sample. Readings started 
after 5 minutes reaction time and taken every 1-5 minutes until stabilization occurred. 






Figure 8. Absorbency versus time of day 7 control sample. Readings started after 5 
minutes reaction time and taken every 1-5 minutes until stabilization occurred. Stable 




Figure 9. Absorbency versus time of day 7 DSS-treated sample. Readings started after 5 
minutes reaction time and taken every 1-5 minutes until stabilization occurred. Stable 







Figure 10. Absorbency versus time of day 7 antibiotic-treated sample. Readings started 
after 5 minutes reaction time and taken every 1-5 minutes until stabilization occurred. 





Figure 11. Absorbance readings versus stable concentration of nitrate anion (ug/ml) as 
depicted in previous graphs. Stable time point was selected from each sample and entered 




































Concentration of Nitrate Anion (ug/ml) with Corresponding Sample





Sample with respective nitrate concentration 
 
Sample D1C1 D1E1 D1R1 D3C3 D3E3 D3R3 D7C7 D7E7 D7R7 
Nitrate 0.0182 0.0574 0.0132 0.0077 0.0139 0.08 0.0145 0.0579 0.0195 
Note: Sample with normalized measure of nitrate, determined by micrograms of nitrate 
anion (shown in Figure 11) per gram of fish weight.  
 
16S rRNA Sequencing. Rarefaction curves plot the alpha-diversity (in this case 
the number of OTUs) found within a given number of observations. The rarefaction curve 
(Figure 12) is suggestive of sufficient sequencing to to be representative of the total 
diversity of the sampled communities. 
Figure 12. Rarefaction curve generated using RStudio (command rarefy in vegan 
package). Curves are labeled with respective samples and their number of OTUs at  

















Note: Good’s coverage estimates of 99.5-99.7% indicate that nearly the full extent of the 
microbial diversity in the intestines of 9 animals was captured. 
 
Analysis of species across samples revealed that species from the genera 
Aeromonas were the dominant species and made up the top 5 species across samples 
while Cetobacterium somerae was higher abundance in the day 1 antibiotic treated fish 
(22%). Similarly, species such as Mycoplasma spp. were rare across samples with the 
exception of the day 1 antibiotic treated fish in which there was an increase to 15% of the 
community. Patterns such as these were seen across antibiotic treated samples and also 
across day 7 samples.  
Sample no.sing no.seqs goods
D1C1 157 54868 99.71385872
D1E1 173 44374 99.61013206
D1R1 204 45741 99.55401063
D3C3 192 52781 99.63623274
D3E3 171 53693 99.68152273
D3R3 154 73790 99.79129963
D7C7 184 66250 99.72226415
D7E7 215 66289 99.67566263




Figure 13. Species present at 1% or greater abundance in at least one of the samples in 
days 1, 3, or 7 denoted as D1, D3, and D7, respectively. Here, “C,” “E,” and “R” 
represent the control, DSS-treated, and rifampicin-treated fish, respectively. “Other” 

















D1C1 D1E1 D1R1 D3C3 D3E3 D3R3 D7C7 D7E7 D7R7
Dominant species in all samples
aeromonas veronii aeromonas salmonicida
aeromonas hydrophila aeromonas spp.
aeromonas sp. cetobacterium somerae
aeromonas sobria aeromonas popoffii
shewanella putrefaciens aeromonas jandaei
aeromonas media shigella sonnei
shewanella profunda vogesella spp.
aeromonas sharmana aeromonas caviae
candidatus arthromitus sp. sfb_mouse mycoplasma spp.
flavobacterium succinicans spirochaeta spp.
comamonas testosteroni brevundimonas vesicularis




Figure 14. Species of Aeromonas present across samples. Abundances shown are average 
percentage.  
 
 Analysis of species of Aeromonas across rifampicin-treated samples revealed a 
lower overall abundance of Aeromonas within the community on days 1 and 3 of 
antibiotic treatment, but that by day 7 the community appeared to re-normalize, 
recovering overall abundance and similar composition of the individual species. The 
control and DSS-treated had different patterns of declining abundance from 1 to 3 to 7 
days. In all cases, while the overall abundance of the genus Aeromonas changes between 
samples, the proportions of each species within the genus seem relatively stable.  
Upon closer inspection of the 16S rRNA sequencing community data, it was 
observed that certain species of bacteria became more pronounced across the day 7 
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samples. For example, Bosea sp. was in relatively rare abundance (no greater than 0.60% 
in the day 3 control fish) until day 7 during which there was an increase to 14.20% in the 
control, 6.38% in the DSS treated fish, and 2.93% in the antibiotic treated fish. Similarly, 
Sinorhizobium meliloti was rare in day 1 and 3 samples (no greater than 0.23% in the day 
1 antibiotic treated fish) and increased to 7.92%, 3.06%, and 1.40% in the day 7 control, 
DSS treated, and antibiotic treated fish, respectively. It should be noted that these species 
are either aerobic (such as Bosea sp. which is a strict aerobe) or nitrogen-fixing (such a 
Rhizobium and Sinorhizobium meliloti).  
 
 
Figure 15. Aerobic and Nitrogen-fixing bacteria that are unique to day 7 samples.  
*Bosea sp., Reyranella massiliensis, and Ensifer sp. are aerobic **Rhizobium are 
nitrogen-fixing  
 
An analysis of dominant genera across all of the samples revealed that Aeromonas 
dominate the majority of the samples while other genera make more of an appearance 
possibly based on environmental circumstances such as antibiotic treatment. For 






















Aerobic and Nitrogen-Fixing Bacteria 
bosea sp. sinorhizobium ensifer meliloti
reyranella massiliensis rhizobium sp.




(10.88%),and increased abundance in the antibiotic-treated fish (22.28%). Similarly, 
Pseudomonas was in markedly low abundances (0.7-8%) in samples with the exception 
of the Day 3 antibiotic treated fish (46.40%) and the Day 7 samples (8-26%). This is 
suggestive of antibiotic treatment resulting in profound changes within the community, 
similar to studies done in murine and mammalian models. It is not clear whether 
inflammation could have a similar influence on the community within the guts of the 
Gambusia as MPO levels in the experimental fish were unreliable.  
 
 
Figure 16. Genera present at 1% or greater in at least one sample on days 1, 3, and 7 
denoted as D1, D3, and D7, respectively. Here, “C,” “E,” and “R” represent the control, 
dextran sulfate sodium-treated, and rifampicin-treated fish, respectively. “Other” 




























Dominant Genera Across Samples 
acinetobacter aeromonas bacillus bosea candidatus
cetobacterium chitinilyticum chryseobacterium enterobactum ensifer
flavobacterium mycobacterium pelomonas pantoea pseudomonas




An average of the dominant genera within the DSS treated group revealed Aeromonas 
made up 60% of the dominant taxa while Pseudomonas, Cetobacterium, and Shewanella 
together constituted approximately 20% of the dominant genera (Figure 14). 
Additionally, within the antibiotic treated samples, Aeromonas makes up 26% of the 
community while Pseudomonas makes up approximately 25% of the community, thereby 
making up half 
the dominant genera across those samples. Furthermore, Cetobacterium, Candidatus 
Arthrimotus, Mycoplasma, and Acinetobacter together make up approximately 27% of 






Figure 17. Pie chart of dominant genera of the gut microbiome across dextran sulfate 
sodium treated fish. Abundances shown are average percentage.  
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Figure 18. Pie chart of the dominant genera of the gut microbiome across Rifampicin 
treated fish. Abundances shown are average percentages.  
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Additionally, further analyses of genera across samples revealed that certain genera are 
unique to particular samples (Figure 7), suggestive of diversity across samples.    
                                  
Genera unique to D7E7:    71 unique genera total (g diversity). 
Planctomyces, Legionella, Aciditerrimonas                54% common to all 3 samples,  
             Genera unique to D7R7                                  21% unique to d7 sample.  
       Fusobacterium, Sphingomonas,  
        Rheinheimera, Sphingobium 
Figure 19. Venn diagram comparison of selected samples.  
Figure 20. Alpha diversity of all nine samples.  
Analysis of beta species diversity as represented by Whittaker dissimilarity 
indices revealed that some of the more similar samples were between D1E1 and D3C3, 
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D1E3; D3C3 and D3E3 and the D7 samples; and Day 7 samples as compared to each 
other while some of the more diverse samples were D1C1 and D1R1; D1E1 and D3R3; 
and D1R1 and D7E7. Unsurprisingly, a lot of these similarities and diversities are 
reflected in the changes in percentages as represented by the bar graph in Figure 4 and 
can also be observed among genera in Figure 7.  
Table 15 
Beta Species Diversity as Represented by Whittaker Dissimilarity Indices 























































































































































 Note: Beta species diversity as represented by Whittaker dissimilarity indices where “0” 
indicates identical species and “1” indicates perfect diversity in which no species is 
shared between the samples.  









Beta Genus Diversity as Represented by Whittaker Dissimilarity Indices  
 
Note: Beta genus diversity as represented by Whittaker dissimilarity indices where “0” 
indicates identical species and “1” indicates perfect diversity in which no species is 
shared between the samples.  
            
 Species-level identification of the short sequences in our data is not very 
accurate. Genus-level identification is more confident. As a comparison, sequence data 
was also compared at a much higher level of taxonomy (Class level, which is three steps 
above genus; species, genus, family, order, then class). The most dominant class across 
all fish was Gamma Proteobacteria, not a surprise since this class include the genera 
Aeromonas and Pseudomonas. The second-most dominant class was Alpha 
Proteobacteria, which includes the genera Bosea and Ensifer. With the exception of the 
day1 rifampicin-treated fish, the Proteobacteria make up more than 75% of the gut 
microbiome of the fish. This is consistent with other studies of fish, where Proteobacteria 
dominate (14, 19, 23). 
D1C1 D1E1 D1R1 D3C3 D3E3 D3R3 D7C7 D7E7 D7R7
D1C1 0 0.41818 0.48936 0.44706 0.46405 0.40782 0.48187 0.50754 0.39
D1E1 0.41818 0 0.4386 0.28105 0.26471 0.49383 0.39773 0.38462 0.333333
D1R1 0.48936 0.4386 0 0.53409 0.50943 0.37297 0.52764 0.53171 0.42718
D3C3 0.44706 0.28105 0.53409 0 0.26241 0.48503 0.28177 0.30481 0.34043
D3E3 0.46405 0.26471 0.50943 0.26241 0 0.52 0.35366 0.4 0.35673
D3R3 0.40782 0.49383 0.37297 0.48503 0.52 0 0.48421 0.52041 0.42132
D7C7 0.48187 0.39773 0.52764 0.28177 0.35366 0.48421 0 0.20952 0.31754
D7E7 0.50754 0.38462 0.53171 0.30481 0.4 0.52041 0.20952 0 0.33641




Figure 21. Normalized abundance at class level.  
 Non-metric multidimensional scaling (NMDS) shows differences in the day 1 
antibiotic treated fish as well as in the Day 7 fish across samples as compared to the other 












D1C1 D1E1 D1R1 D3C3 D3E3 D3R3 D7C7 D7E7 D7R7
Normalized Abundance at Class Level
saccharomycetes opitutae fusobacteriia dothideomycetes
actinobacteria bacteroidia liliopsida clostridia
epsilonproteobacteria sphingobacteriia deinococci spirochaetia
deltaproteobacteria betaproteobacteria phaeophyceae streptophyta
mollicutes eukaryota chlamydiia cyanobacteria
actinopteri fragilariophyceae planctomycetia negativicutes
methanobacteria verrucomicrobiae coccidia gammaproteobacteria
caldilineae heterolobosea trebouxiophyceae bacilli
kickxellomycotina alphaproteobacteria cytophagia flavobacteriia
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Figure 22. Non-metric multidimensional scaling (NMDS) to visualize differences in 
overall community (all genera 0.1% abundance or higher in at least one sample) 
























The anatomy of the Gambusia affinis is similar to that of the zebrafish (Menke et al., 
2011): intestinal folds lined by absorptive cells with the presence of goblet cells. A 
healthy intestinal tract is noted for its defined architecture, epithelial integrity, and not 
overly abundant presence of leukocytes at the base of the folds. Pictured below, Figure 
20, is an example of a healthy, “normal” section of the intestinal tract. As can be 
observed, the architecture of the folds is well defined, the epithelium is intact, and while 
there is a presence of leukocytes, they do not overwhelm the presence of other cells: 
 






In Figure 27-28, on the other hand, a complete disruption of the architecture as well as 
the epithelial integrity can be observed. There is also a significant infiltration of 
leukocytes, suggestive of acute inflammation in this region.  
 































CFU Counts and Plating.  
In order to further validate observations made based on sequencing data, an aerobic 
versus anaerobic plating experiment was conducted. Here, the experimental design was 
set up as previously outlined: fish were removed from the aquarium, weighed, and placed 
into individual Styrofoam cups. The control and antibiotic-treated fish were fed regular 
gelatin feed while the dextran sodium sulfate-treated fish were fed gelatin feed that 
contained the dextran sulfate sodium colitogen. As before, fish intestines were excised on 
days 1, 3, and 7, cut into small pieces, placed in 1.5 ml tubes containing PBST, and 
vortexed for 1 minute on 01-29-2019 and for 2 minutes after resting in PBST for 5 
minutes on days 3 and 7. Afterwards, standard dilutions were made and 100 µl of the 1X 
and the dilutions were plated onto both nitrate and nutrient agar plates and placed into a 
25°C incubator under both aerobic and anaerobic conditions (plates denoted for anaerobic 
conditions are placed into anaerobic chambers). After approximately 72 hours, plates 
were noted for growth and CFU counts were documented.  
 *It was noted that the first gut excision did not produce substantial results. For 











Calculated CFUs Under Aerobic Conditions 
 
Table 18 
Calculated CFUs Under Anaerobic Conditions 
 
Note: The tables above denote the calculated colony forming units (CFUs) for each 
respective plate (nitrate or nutrient agar) under either aerobic or anaerobic conditions. 
The dilutions are listed under the respective group of fish (C=control, E=DSS-treated, 
and R=rifampicin-treated). “TFTC” is “too few to count” meaning that the colonies were 
under 20.  
 




C3 1.36 x 105       2.8 x 105
E3 3.12 x 105 9.4 x 104
R3 3.1 x 102 TFTC
C7 TFTC TFTC
E7 3.0 x 105 TMTC
R7 TFTC TFTC
Sample Nutrient Agar Nitrate Agar 
C1 no growth TFTC
E1 no growth no growth 
R1 no growth no growth 
C3 2.7 x 105 1.0 x 104
E3 2.3 x 105 2.52 x 105
R3 no growth no growth 
C7 no growth no growth 
E7 1.3 x 105 9.7 x 104
R7 no growth no growth 
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Anaerobic to Aerobic Plating. In all cases, when colonies were taken from anaerobic 
conditions on either nitrate or nutrient agar and inoculated onto nutrient agar plates and 
stored at 25°C for approximately 48-72 hours, growth was observed. However, CFU 
counts were not possible due to the lack of individual colonies formed. Nevertheless, this 
is suggestive of facultative anaerobes present within the gut of the Gambusia affinis. On 
the other hand, when colonies were inoculated from aerobic conditions and stored at 
25°C in anaerobic chambers for 48-72 hours, growth was not observed in all cases. For 
example, when colonies were taken from sample C3 (10-3 dilution), originally plated on 
02.06.2019 (representative of day 7 samples) on nitrate agar and grown under aerobic 
conditions, no growth was observed. This is suggestive of bacteria present which are 






CHAPTER IV  
DISCUSSION  
Inflammation 
While the MPO pre-trials were suggestive of inflammation induced by DSS both 
at 6 mg and at 20 mg doses, trial results were unclear. Additional experiments conducted 
in an attempt to isolate and purify the MPO enzyme also failed to illuminate the 
reliability of this method. It is possible that the lack of specificity of o-dianisidine 
towards MPO makes this method unreliable overall. As Pulli et al point out, o-
dianisidine, along with TMB and guaiacol, are general peroxidase substrates and 
therefore do not interact with MPO alone27. Nevertheless, the MPO assay utilized in this 
experiment is one that is used widely in the literature in murine and zebrafish models. It 
is also possible that this particular approach cannot be used reliably in Gambusia affinis. 
Two major hurdles in this experiment were avoiding female fish who were not pregnant 
and fish without parasites: it is not clear the ways in which pregnancy affects Gambusia 
affinis specifically, so it not known what peroxidases are present or elevated as a result. 
Additionally, as these fish were caught in the wild and are not bred in a lab, parasitic 
infections were relatively common and although care was taken to omit those infected, it 
is possible that other infections (perhaps not immediately apparent) interfered with MPO 
measurements such that control fish may have had greater inflammation than the dextran 
sodium sulfate-treated fish.  
 Furthermore, it is also possible that the initial gut microbiota structure is too 
variable between the fish. Although the fish are homogenous in that they come from the 
same pond, they are nevertheless wild and may perhaps exhibit nuances within their 
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individual gut microbiomes that could interfere with results which are dependent on 
generalizations within a “core” microbiome. As is seen in the data from previous work by 
Carlson et al., significant variations in the control gut microbiome data are observed as 
compared to the control fish within this experimental design. See pie charts below:  
 
Figure 26. Chart taken from unpublished, raw data of control gut samples (n= 4) from 




Figure 27. Average of control gut samples (n = 3), genus level.  
For this reason, it may be necessary to conduct 16S rRNA sequencing on a large 
population of fish in order to assess what a “core” microbiome may look like within the 
Gambusia. This data would further illuminate whether the initial gut microbiome of the 
individual fish plays a role in the effectiveness of dextran sulfate sodium. As Li et al 
point out in a study conducted in mice, the initial structure of the gut microbiome affects 
the sensitivity to DSS-induced colitis (2017). For this reason, it is possible that whatever 
the initial gut microbiota was prior to treatment with DSS affected the results and may 
therefore explain the inconsistency of the assay on this organism. 
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The nitrate assay reveals slightly higher values of the nitrate anion in both the day 
1 and day 7 DSS-treated fish. Interestingly, the day 3 antibiotic-treated fish reveals 
slightly elevated levels of nitrate anion as well. While the DSS-treated fish do appear to 
have higher levels across samples with an average of 0.04 micrograms of nitrate anion 
per gram of fish weight as compared to 0.01 and 0.03 in the control and antibiotic treated 
samples, respectively, these values do not necessarily explain the differences seen within 
the sequence data. For example, while the day 1 DSS treated sample has a higher value of 
nitrate anion at 0.05 than either of the day 1 control or antibiotic treated samples, its 
community composition is more similar to the control sample than the antibiotic treated 
sample which undergoes a dramatic shift in its community composition. Similarly, while 
the day 7 DSS-treated sample reveals higher levels of the nitrate anion, and while the 
community shifts to a higher abundance of aerobic and/or nitrate-fixing microbes, an 
increase in the nitrate anion alone cannot account for this shift as similar shifts are 
observed in the day 7 control and antibiotic treated samples which show decreased levels 
of the nitrate anion. In this way, potential inflammation as represented by nitrate anion 
values cannot adequately explain community shifts within the Gambusia samples. 
Instead, other factors need to be considered. Perhaps starvation plays a role in the ways in 
which the gut microbiome is affected. In a study conducted by Xia et al., sequencing 
analysis of the gut microbiome of the Asian seabass Lates calcarifer after eight days 
under starvation revealed dramatic differences in microbial community composition as 
compared to the regularly fed cohort (2014). In this way, it is possible that the day 7 fish 
that have not eaten since day 0 of the experiment are experiencing similar compositional 
shifts due to experiencing the same dietary restrictions. Additionally, Winters et al 
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conduct their research in mice which, like humans, are dominated by obligate anaerobes 
within the colon and it is for this reason that the nitrate anion offers a selective advantage 
for the facultative anaerobes as they can use the nitrate anion and perform nitrate 
respiration. It is not yet clear how this mechanism may be used by facultative anaerobes 
and how this may change the community composition of Gambusia affinis specifically. 
Human and murine intestinal communities are normally dominated by obligate 
anaerobes, while our fish is dominated by facultative anaerobes. So, the theory from 
Winters related to inflammation and nitrate does not apply. Furthermore, it should be 
noted that fish like zebrafish and salmonids like trout are dominated by aerobes or 
facultative aerobes (Roeselers et al., 2011) while large aquatic animals such as sperm 
whales are dominated by obligate anaerobes (Erwin high diversity and unique comp). In 
this way, the tendency toward aerobic and facultative aerobic microbial communities is 
not true of aquatic animals in general, as may be assumed, but instead appears to be true 
for non-mammalian aquatic animals. This observation brings into question the validity of 
using zebrafish for gut microbiome studies as they apply to human models. It is possible 
that the intricacies and complexities of the gut microbiome is too species specific, such 
that translating gut microbiome studies is currently limited to murine and mammalian 
studies.  
16S rRNA Sequencing 
Results of 16S rRNA sequencing revealed that the first and third days of 
rifampicin treatment disrupted the gut microbiome of the Gambusia fish profoundly. On 
the first day, the genus Aeromonas was in an abundance of approximately 15% as 
compared to approximately 82% in both the control and the dextran sodium sulfate-
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treated fish. Additionally, the community shifts such that Cetobacterium, Candidatus, 
and Mycobacterium become pronounced at 22%, 20%, and 15%, respectively, whereas 
Candidatus and Mycobacterium are either rare or nonexistent across the other samples. 
On day 3 (two days post-antibiotic treatment), there is a marked abundance in 
Acinetobacter at approximately 22%, whereas it is rare (0.5% or less) across all other 
samples with the exception of the day 3 DSS treated fish (two days post-DSS treatment) 
in which it is at 7% abundance. Furthermore, there is a marked abundance of 
Pseudomonas at 46%. Interestingly, Pseudomonas emerges in the day 7 control, DSS 
treated, and antibiotic treated samples at 8%, 12%, and 26%, respectively. Of note, based 
on other gut samples (n=3) from previous work done in the lab, Pseudomonas was in low 
abundance in the control fish (prior to antibiotic treatment), at 0.8% and lower. In 
recovery samples, Pseudomonas remained low. It should be noted, however, that the fish 
underwent treatment and recovery over the span of a two weeks (one week for treatment, 
one week for recovery), thus the community was impacted and experienced shifts that 
cannot adequately and reliably be compared to this experimental design. Nevertheless, 
with so little known about the gut microbiome of the Gambusia affinis, comparisons such 
as these are helpful in gaining insight into the possible core microbiome of this potential 
model and the ways in which various environmental factors and chemicals may affect 
that microbiome.  
Additionally, Bosea and Ensifer emerge across day 7 samples, both of which are 
obligate aerobes as opposed to the facultatively anaerobic Aeromonas. In fact, a number 
of aerobes are in day 7 samples which are in very low abundance across the other 
samples. As is seen in Figure 4, a pattern of emergence can be seen across day 7 samples. 
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For example, in the day 7 control sample, Bosea sp. is an obligate aerobe, Ensifer 
adherens is aerobic and Ensifer meliloti, and Reyranella massiliensis are both 
microaerophilic. The day 7 DSS-treated fish exhibits Bosea, Pseudomonas straminae, 
and Pseudomonas putida, all of which are aerobes or obligate aerobes. The day 7 
antibiotic treated fish, similar to the DSS-treated fish, also exhibits an increase in 
Pseudomonas straminea and Pseudomonas putida along with a re-emergence of 
Aeromonas species such as Aermonas salmonicida and Aeromonas veronii. The theory of 
Winters is that in the mammalian gut, which is normally dominated by obligate 
anaerobes), release of nitrate during inflammation gives a metabolic advantage to 
facultative anaerobes (using the nitrate during anaerobic respiration). This does not apply 
in our fish, as they are normally dominated by facultative anaerobes. However, future 
work can examine a possibility suggested by this work, that inflammation in the fish gut 
causes an increase in abundance of obligate aerobes compared to facultative. Perhaps this 
results from oxidative radicals being released in the gut. 
 When comparing dextran sodium sulfate treated fish to antibiotic treated fish, 
patterns can be seen within the averages across samples. In Figure 5, Aeromonas 
comprises approximately 60% of the genera present while in antibiotic treated fish, 
Aeromonas comprises approximately 26% of the community while Pseudomonas 
comprises approximately 24%. In this way, the two groups are dissimilar to one another. 
 In reviewing the beta genus diversity as represented by Whittaker dissimilarity 
indices, again, these patterns in genera lost and gained and differences in community 
composition, as represented in Figures 3-8 (not set until nitrate done), can be observed. 
For example, a beta diversity index of 0.48 exists between D1C1 and D1R1. In this way, 
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D1C1 and D1R1 are more diverse than D7C7 and D7E7 which have a dissimilarity index 
of only 0.19.. When D7C7 is then compared to D7R7, for example, a beta diversity index 
of 0.25 is noted. Additionally, D7E7 compared to D7R7 resulted in a beta diversity index 
of 0.25.  In this way, the day 7 DSS treated fish is more similar to the control fish than 
the antibiotic treated fishIn this way, antibiotic disruption may be more dramatic than 
DSS disruption as conducted in this experiment. Furthermore, when samples are 
compared among groups, the DSS treated groups remain relatively similar to one another, 
resulting in indices between 0.28 and 0.35 while the control and the antibiotic treated 
groups remain more dissimilar across their own groups, ranging between 0.27-0.41 and 
0.36-0.42, respectively. These patterns can be observed in the NMDS as well. While 
these patterns are notable, they cannot be adequately explained by either MPO or the 
nitrate anion. This suggests that rifampicin is more disruptive to the gut microbiome than 
DSS, which is not a surprise. Alternatively, it may take longer for the DSS effects to 
manifest. 
Histology 
Histological samples were prepared at Texas Tech Health Sciences Center and 
analyzed by Derek Fleming, a post-doctoral research associate in Dr. Kendra 
Rumbaugh’s lab. Dr. Rumbaugh also inspected the images and confirmed Dr. Fleming’s 
conclusions. From all nine samples, it was concluded that the day 3 untreated and day 7 
DSS-treated samples were most different from what is regarded as “healthy” or “normal” 
tissue, which is characterized by a well-defined tissue structure with intact crypts and 
epithelia. Additionally, there was not an overabundance of leukocytes/lymphocytes 
beyond what is expected in the colon, which itself houses a great deal of immune cells. In 
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this way, the first image in the histology section is from the day 7 Rifampicin-treated fish 
gut and represents normal tissue. Here, there is an observable and defined structure 
without a massive infiltration of immune cells. On the other hand, in the second and third 
images, there is significant architectural disruption, reduction of goblet cells, and a 
noticeable infiltration of immune cells. Of note, Dr. Fleming did not detect the 
appearance of neutrophils as he has characterized them in mammalian and murine gut 
samples but did note what could be a large amount of monocytes. Additionally, an in-
depth paper on the intestinal histology of Gambusia affinis reveals what is seen in our 
study: folds covered by simple columnar epithelium with the presence of Goblet cells and 
macrophages. There is no mention of neutrophils, however (bullock). This raises the 
question of whether it is possible that Gambusia lack neutrophils. If they do, then the 
MPO data is not representative of neutrophil activity, but rather of monocyte/macrophage 
activity.  
 While Dr. Fleming did not provide official scores for the histological samples, 
samples are typically analyzed and severity of disease assessed in the following manner:  
bowel-wall thickening (0  normal, 1= slightly thickened, 2 = moderately thickened, 3 = 
severely thickened), intestinal-fold architecture disruption (0 = normal, 1 = slight 
disruption, 2 = moderate disruption [characterized by increased interfold distance and/or 
disruption of epithelial integrity], 3 = severe disruption), goblet cell appearance (0 = 
normal, 1 = decreased in number or size, 2 = complete depletion), and infiltration of 
leukocyte/ granular cells (0 = sporadic, 1 = some scattered cells, 2 = clusters of 
infiltrating cells at base of the folds, 3 = massive infiltrates, clusters of infiltrating cells at 
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the base and tips of the folds). Using this general scale, Dr. Fleming assessed the samples 
and provided me with his impressions. The samples were de-identified prior to analysis.  
 The results of the histological analysis suggest that the possible inflammation 
seen in the day 3 untreated fish and the day 7 DSS-treated fish is likely due to 
confounding factors and individual heterogeneity and not the result of treatment as both 
the control and the DSS-treated samples exhibit possible inflammation. The results thus 
also suggest that the DSS, at least as it is utilized in this study, is possibly not an effective 
colitogen in this model. This could be due to the fact that the amount of DSS is too low, 
that the bacterial communities of the fish combat its effects, or that the method of 
ingestion is ineffective. In a study by Oehelers, zebrafish larvae were exposed to DSS 
through immersion. In mice, however, DSS is administered through the drinking water.  
     Finally, the aerobic and anaerobic CFU counts on either nitrate or nutrient agar are 
inconclusive. Day 1 samples revealed nothing due to possibly vortexing the tissue 
samples too quickly after placing them in PBST, thereby not allowing the detergent to 
work properly. Day 3 samples revealed growth, both aerobically and anaerobically and 
on nitrate and nutrient agar, in the control and DSS-treated samples but not in the 
antibiotic treated samples. Day 7 samples revealed a significant amount of growth, both 
aerobically and anaerobically, in the DSS treated samples but not in the control or 
antibiotic-treated samples. Furthermore, when colonies were inoculated from anaerobic 
conditions onto nutrient agar and stored under aerobic conditions, growth was noted 
across samples. Of note, however, was that when day 7 samples were taken from the 
control fish and the DSS-treated fish, growth was not observed in the control but was 
observed in the DSS-treated sample.  
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Additional MPO statistics  
An additional focus was placed on MPO activity. Using the same experimental design as 
before (with the exception that Rifampicin-treated fish were eliminated), a total of five 
fish were used per category per day. Thus, there were five untreated fish for days 1, 3, 
and 7 and five DSS-treated fish for days 1, 3, and 7 for a total of thirty fish. The MPO 
assay was run on each gut sample. For statistical analysis, graphs illustrating mean 
absorbances with standard deviation bars were created and a pairwise t-test was run on 
each group comparing untreated to DSS-treated samples:  
 
 
Figure 28. Mean MPO Control vs DSS Day 1 
Table 19 
T-test on additional MPO samples, n=5 
  Control DSS 
Mean 23.02 13.24 
Observations  5 5 
Hypothesized mean difference  0 206.963 
  (continued) 
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Observations 5 5 
t Stat 0.726681   
P(T<=t) two-tail 0.494784   
t Critical two-tail  2.446912   
 
 
Figure 29. Mean MPO Control vs DSS Day 3 
Table 20 
T-test on additional MPO samples, n=5 
  Control DSS 
Mean 1.3 4.364 
Observations 5 5 
Hypothesized Mean Difference 0   
t Stat 0.8717   
P(T<=t) two-tail 0.432567   








Figure 30. Mean MPO Control vs DSS Day 7 
Table 21 
T-test on additional MPO samples, n=5 
  Control DSS 
Mean 7.4 3.86 
Observations 5 5 
Hypothesized Mean Difference 0   
t Stat 0.922094   
P(T<=t) two-tail 0.383446   
t Critical two-tail 2.306004   
 
The results of this statistical analysis indicate that there is not a significant difference 
between the untreated fish versus DSS-treated fish as measured by the MPO assay. Based 
on the analyses of the data and results of the first set of nine fish, this is not altogether 
surprising. As previously discussed, it is possible that DSS, at least in the amount utilized 
in this study, is not sufficient to consistently induce inflammation. It is also possible that 
the microbiota of the Gambusia is such that any inflammation induced by administration 
of DSS is attenuated, or some other as yet undetermined confounding factor (such as 
pregnancy or genetic predisposition) may be behind the lack of consistency. Further 
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studies need to be conducted before conclusions can be drawn. Gambusia may be a good 
gut microbiome model to explore fish-related topics, such as probiotics or antibiotics or 
pathogens in commercial fish farms. However, this work suggests it is not a good model 
for mammalian gut inflammatory diseases, due to two primary factors that were 
uncovered in this study. First, while the healthy mammalian gut is dominated by obligate 
anaerobes, and a shift to more facultative anaerobes is a disease marker, instead the fish 
gut is already normally dominated by facultative taxa. Secondly, while a shift to more 
Proteobacteria is a potential marker of dysbiosis and inflammation in the mammalian gut 
(4), the fish gut is normally dominated by Proteobacteria. So, while the “oxygen 
hypothesis” of Winter and colleagues that oxidative radicals released during gut 
inflammation metabolically drive a shift in the mammalian gut microbiome is very 
promising for human health, it may not apply to fish. This deserves future study, since 
fish are the largest group of vertebrates on Earth. 
Future Work 
While this study contributes to things not previously known about Gambusia 
affinis, it is nevertheless preliminary and exploratory. With such a small  
sample size, it is impossible to draw conclusions or make predictions with confidence. As 
such, future work should include a large sample size on which larger comparisons can be 
made and statistical analyses conducted. Additionally, it would be beneficial to conduct a 
sequence-based study on a large population of Gambusia in order to assess a “core” 
microbiome that can then be compared to experimentally treated microbiomes. 
Furthermore, as 20 mg of DSS administered through the gelatin fish food ultimately did 
not yield consistent and reliable results, future work should include separating fish into 
74 
 
individual Styrofoam cups and conducting a toxicity experiment in which the levels 
amounts of DSS are increased until there is a mortality. It is possible that 20 mg of DSS 
simply is not enough to induce colitis in Gambusia affinis, which are known for being 
rather resilient fish.Lastly, it is possible that wild caught Gambusia have too many 
inherent confounding factors to be used reliably in gut microbiome research. Should this 
study be explored further, it may be beneficial to order Gambusia bred in a lab where 
confounding factors such parasites and pregnancies can be avoided. To explore the 
potential relationship between nitrate during inflammation and DSS, an additional control 
group should be used in future experiments. This group of fish would have nitrate added 
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